JavaScript is disabled for your browser. Some features of this site may not work without it.
Get the latest COVID-19 technical guidance, scientific and policy briefs here.✕
    • العربية
    • 中文
    • English
    • français
    • русский
    • español
    • Deutsch
    • português
English
  • العربية
  • 中文
  • English
  • français
  • русский
  • español
  • Deutsch
  • português
  • Home
  • Contact
  • Help

Browse

All of IRISCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

Statistics

Most PopularBy Country

Related Links

PAHO IRIS

SEA/RC67/20 - Consultative Expert Working Group on Research and Development: Financing and Coordination (‎SEA/RC65/R3)‎

Thumbnail
View/Open
RC67-20 Agenda 9.7 - Consultative Expert Working Group.pdf (‎209.1Kb)‎
View Statistics
Show Statistical Information
Altmetrics
Share
  • CSV
  • Excel
  • BibTeX
  • RIS
Abstract
The Sixty-fifth Session of the WHO Regional Committee for South-East Asia held in Yogyakarta, Indonesia, adopted resolution SEA/RC65/R3 that outlined detailed recommendations and action points for Member States and WHO on the follow-up of the Consultative Expert Working Group on Research and Development: Financing and Coordination (‎CEWG)‎. The Regional Committee resolution provided the basis for the draft resolution during the open-ended meeting of all WHO Member States, held from 26 to 28 November 2012 in Geneva, leading to WHA66.22 in 2013. As a result, the objectives and actions outlined in SEA/RC65/R3 are included in WHA66.22. Therefore, actions taken for WHA66.22 cover both the Regional Committee and World Health Assembly resolutions. Resolution WHA66.22 calls for:(‎1)‎specific actions* through a strategic workplan to improve monitoring and coordination, and to ensure sustainable funding for health research and development (‎R&D)‎ (‎in line with WHA61.21, Global Strategy and Plan of Action)‎; and (‎2)‎identification of a few health R&D demonstration projects as a step towards achieving the goal of development and the delivery of affordable, effective, safe and high-quality health products.To take resolutions SEA/RC65/R3 and WHA66.22 forward, the Regional Office organized the following meetings:(‎1)‎Regional consultation to develop a strategic workplan as a follow-up of the meeting of the Consultative Expert Working Group on Research and Development: Financing and Coordination, 25–26 July 2013, in Bangkok, Thailand. This meeting has suggested an important grid for classification of norms and standards for health R&D in the proposed observatory and also identified the priority areas for demonstration projects. The recommendations of this regional consultation are at Annex 1.(‎2)‎Meeting of Experts on Demonstration Projects, New Delhi, India, 24–25 October 2013, facilitated the submission of projects at the global level by Member States of the South-East Asia Region. Of the four projects submitted by the WHO Regional Office, the “Multiplexed point-of-care test for acute febrile illness” scored 45.50 points and was placed second and “Dengue vaccine development” – which did not meet the 60% bar, but was the eighth highest-scoring project – was selected and is the “7+1” project. The meeting to examine the additional information in relation to the “7+1” demonstration projects held on 10 March 2014 at WHO headquarters did not take up the projects submitted by the WHO Regional Office. However, by decision WHA67(‎15)‎, Member States have requested the Director-General to expedite the processing of the remaining projects in addition to the four already agreed. The High-Level Preparatory (‎HLP)‎ Meeting held in the Regional Office in New Delhi, India, from 14 to 17 July 2014 reviewed the attached working paper and made the following recommendations:Actions by Member States(‎1)‎To take forward the strategic workplan for the Region as a follow-up of the CEWG on Research and Development: Financing and Coordination.(‎2)‎To engage in promoting and strengthening health R&D, including coordination, monitoring and capacity-building through assessment of the Global Strategy and Plan of Action.(‎3)‎To further engage in developing health R&D demonstration projects for the addition of innovative components and financing.Actions by the WHO Regional Office(‎1)‎To provide technical assistance to countries on the CEWG on Research and Development: Financing and Coordination process, including the assessment of the Global Strategy and Plan of Action(‎2)‎To promote information-sharing mechanisms in respect of health R&D, including employing the Global Health R&D Observatory for this purpose(‎3)‎To support the further development of health R&D demonstration projects for the addition of innovative components and financing.The working paper and the HLP recommendations are submitted to the Sixty-seventh Session of the Regional Committee for its consideration.
Citation
World Health Organization. Regional Office for South-East Asia. (‎2014)‎. SEA/RC67/20 - Consultative Expert Working Group on Research and Development: Financing and Coordination (‎SEA/RC65/R3)‎. WHO Regional Office for South-East Asia. https://apps.who.int/iris/handle/10665/129383
Document number
SEA/RC67/20
Language
English
Collections
  • Regional Committee Meeting 67 Dhaka, Bangladesh, 10-12 September 2014
Metadata
Show full item record

Show Statistical Information

View Item 
  • IRIS Home
  • 6. Regional Office for South-East Asia
  • Regional Committee Meeting 67 Dhaka, Bangladesh, 10-12 September 2014
  • View Item
  • IRIS Home
  • 6. Regional Office for South-East Asia
  • Regional Committee Meeting 67 Dhaka, Bangladesh, 10-12 September 2014
  • View Item

© 2021 WHO